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Abstract
Background: Malaria rapid diagnostic tests (RDTs) may assist in diagnosis, improve prescribing practices and
reduce potential drug resistance development. Without understanding operational issues or acceptance and usage
by providers and patients, the costs of these tests may not be justified.
Objectives:  To evaluate the impact of RDTs on prescribing behaviours, assess prescribers' and patients'
perceptions, and identify operational issues during implementation.
Methods: Baseline data were collected at six Tanzanian public dispensaries. RDTs were implemented for eight
weeks and data collected on frequency of RDT use, results, malaria diagnoses and the prescription of antimalarials.
Patients referred for RDTs completed a standardised exit interview. Qualitative methods assessed attitudes
toward and satisfaction with RDTs, perceptions about the test and operational issues related to implementation.
Results: Of 595 patients at baseline, 200 (33%) were diagnosed clinically with malaria but had a negative RDT.
Among the 2519 RDTs performed during implementation, 289 (11.5%) had a negative result and antimalarials
prescribed. The proportion of "over-prescriptions" at baseline was 54.8% (198/365). At weeks four and eight this
decreased to 16.1% (27/168) and 16.4% (42/256) respectively.
A total of 355 patient or parent/caregiver and 21 prescriber individual interviews and 12 focus group discussions
(FGDs) were conducted. Patients, caregivers and providers trusted RDT results, agreed that use of RDTs was
feasible at dispensary level, and perceived that RDTs improved clinical diagnosis. Negative concerns included
community suspicion and fear that RDTs were HIV tests, the need for additional supervision in interpreting the
results, and increased work loads without added compensation.
Conclusion: Overprescriptions decreased over the study period. There was a high degree of patient/caregiver
and provider acceptance of and satisfaction with RDTs. Implementation should include community education,
sufficient levels of training and supervision and consideration of the need for additional staff.
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Background
Clinical diagnosis of malaria is sensitive but not specific.
Over-diagnosis and subsequent over-treatment of patients
as a result of clinical diagnosis can lead to increased drug
pressure that may facilitate the development of drug
resistance. This may also increase costs, particularly with
the shift from inexpensive antimalarials (such as chloro-
quine [CQ] and sulphadoxine-pyrimethamine [SP]) to
newer, more expensive drugs. It also exposes patients to
the unnecessary risk of adverse events and, among some
patients, leaves the real cause of illness untreated. In the
current environment of the widespread development of
antimalarial drug resistance and limited treatment
choices, most endemic countries have changed their anti-
malarial drug policies to newer artemisinin-based combi-
nation therapies. Because of the increased cost of these
combination therapies and the need to use them wisely in
order to prolong their usefulness, improvement of
malaria diagnosis has become a critical consideration
when formulating rational malaria drug polices.
Having access to a test that quickly confirms the presence
of malaria parasites could enable the health care provider
to determine whether prescription of antimalarials is
appropriate. Microscopy, though still considered the gold
standard for malaria diagnosis, is not available at most
health facilities. Quality control measures and supervi-
sion are often inadequate or absent, staff are poorly
trained, and equipment is missing or is in need of repair.
Furthermore, clinicians have been known to distrust
microscopy results [1-4].
Malaria rapid diagnostic tests (RDTs) show promise as a
diagnostic tool that requires minimal training and equip-
ment and provides rapid results. RDTs use immunochro-
matographic methods to detect antigens derived from
malaria parasites in lysed blood. In controlled settings,
RDTs have generally been reported to achieve sensitivities
and specificities of > 90% in the detection of Plasmodium
falciparum  at densities above 100 parasites/μL blood.
Below this level, sensitivity decreases markedly. Among
the advantages of the RDT are their ease of use and inter-
pretation. They do not require any electricity or special
equipment. It has been demonstrated in the field that sim-
plified, brief training can result in good retention of skills
and minimal inter-user variability[5,6]. Furthermore, test
kits can be shipped and stored at ambient conditions,
although exposure to high temperatures (as seen in most
malaria endemic areas) can cause the RDT to degrade.
Recommended storage temperatures by the manufactur-
ers tend to fall in the range between 4°C and 30°C but
few health care facilities in resource-poor settings have air-
conditioning or temperature controlled storage units for
drugs or supplies[7]. Findings from a study that examined
temperatures during both transport and storage of RDTs
in Cambodia and the Philippines showed that transport
and storage temperatures both greatly exceeded the rec-
ommended temperatures for field use[7]. In spite of these
challenges, in many situations where microscopy services
are not adequately maintained (in terms of both equip-
ment and personnel), the accuracy of RDTs is certain to be
superior to clinical diagnosis. Despite their relatively high
unit cost ($0.60 – 2.50)[5], RDTs to diagnose malaria are
now being viewed as an important component of rational
malaria case management.
If used appropriately, RDTs could improve clinical pre-
scribing practices and reduce the potential for the devel-
opment of drug resistance. RDTs are beginning to be
implemented in clinical settings but the reality is that
many end-users will be using RDTs in rural clinics with
minimal supervision. Little is known about the accept-
ance and usage of RDT results by providers and patients/
caregivers or field operational issues related to the imple-
mentation of RDTs in the periphery. In a recent study,
Reyburn and colleagues demonstrated that more than
90% of prescriptions for antimalarial drugs in a low-mod-
erate transmission setting were for patients for whom the
malaria test was negative[2]. Their findings also indicated
that use of a RDT, along with training in the use of the test,
did not in itself lead to a lower level of over-treatment for
malaria. RDTs can only promote rational drug use if pro-
viders are willing to use the findings to guide their pre-
scribing behaviors and if patients and parents/caregivers
accept the subsequent treatment (particularly if antima-
larials are not prescribed). Preliminary findings from
recent RDT studies in Kenya, Tanzania and Zambia indi-
cated that 35.5 – 54% of patients with a negative RDT
received antimalarials[2,3] (personal communication, J.
Skarbinski, CDC, 2007). This reinforces other studies
whose findings have documented that up to 79% of
patients with negative blood smears were prescribed anti-
malarials [1-4]. Without understanding whether these
tests can and will be accepted and used appropriately, the
cost of the tests may not be justified and cost-savings from
more rationale use of antimalarials may not be realized.
Socio-behavioural studies have previously documented
that one factor that influences a provider's behavior is
community and/or individual pressure[8,9]. Providers
will often prescribe drugs that have been specifically
requested by patients or caregivers. Alternatively, many
rural health facilities have a very limited number of alter-
native drugs and providers may simply prescribe antima-
larials as nothing else is available. Thus, if antimalarials
are prescribed despite a negative RDT result, it is impor-
tant to identify the factors (social or otherwise) that
weighed more heavily on the prescriptive behaviors than
the test results. Understanding provider attitudes and
behaviors may assist in anticipating the impact of RDTsMalaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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on malaria case management and help guide training and
implementation of these tests.
Although RDTs are simple to use and provide rapid
results, there are operational issues that should be consid-
ered. Factors that may influence RDT results include such
things as buffer and blood volume, age and storage of test
kits and blood samples, visual acuity of person conduct-
ing and interpreting the test, levels of parasitemia, and lev-
els of temperature and humidity [10-12]. Trained staff are
required to perform and interpret test results, yet in many
situations, including much of sub-Saharan Africa, RDTs
will be placed in facilities where staff are poorly educated,
staff attrition may be high and little supervision exists on
a routine basis. Rural dispensaries in Tanzania are often
staffed by one or two persons who need to evaluate 40 or
50 patients a day and the introduction of a test that
requires even an additional 15–20 minutes to perform
may be considered burdensome. It will be important to
understand the strengths and weaknesses of RDTs under
such circumstances, how best to incorporate RDTs into
the routine management of patients at such facilities, and
who is best suited to perform the RDT. In districts where
IMCI (Integrated Management of Childhood Illness) is
implemented (i.e. a formal system of clinical diagnosis
where a child with a history of fever anytime within the
previous 48 hours, feels hot, or temperature > 37.5°C is
considered to have malaria), introduction of an RDT is
likely to face additional operational issues. During a tech-
nical visit to assess implementation of RDTs and ACTs in
nine health facilities in the rural Rufiji district of Tanzania,
it was recently noted that, in spite of having IMCI imple-
mented, health care providers continued to prescribe
RDTs for children under the age of five years, rather than
following the IMCI guidelines. Investigating the impact of
RDTs in these different settings is important to identify
operational issues that may impact the implementation of
RDTs[13].
Lastly, little is known about patients/caregivers' percep-
tions of treatment options offered based on the results of
RDTs. In the best scenario, patients/caregivers would per-
ceive the tests as an important diagnostic service that
would assist the prescriber in more accurately determin-
ing the cause of their or their child's illness. This in turn
might improve patient adherence to antimalarials (in par-
ticular the newer combinations that often have more com-
plex dosing regimens). However, for many years, patients
in Africa received antimalarials for any source of fever.
Thus, expectations for receiving medications, particularly
antimalarials, are high and patients/caregivers often
express their desire for specific drugs. Unless they perceive
the RDTs as a positive improvement in their health care,
they may be reluctant to accept the proposed treatments
that are based on the RDT results, particularly if the test is
negative and they have fever. If this happens, they may
seek antimalarials from private sources, such as pharma-
cies, private clinics or drug stores.
Tanzania has recently implemented artimisinin-based
combination therapy (ACT), specifically using arte-
mether-lumefantrine (Coartem®), for first-line treatment
of uncomplicated malaria. To strengthen malaria diagno-
sis and promote rational drug use, an assessment was
done to evaluate the impact of RDTs on prescribing
behaviors and malaria case management, assess prescrib-
ers' and patients' perceptions about the use of RDTs, and
identify operational issues that impact the use of RDTs at
dispensary level in Tanzania.
Methods
Study site and sample
The study was conducted in 2005 in Mkuranga District (a
rural coastal district within Pwani Region, located approx-
imately 30 kilometres south of the capital city, Dar es
Salaam), an area of year round transmission, with sea-
sonal peaks in May and June. Data from the 2004 Demo-
graphic and Health Survey[14] indicated that 40.3%
children under five years of age in Pwani Region reported
fever within 14 days of the survey. Of these, 71 reported
using an antimalarial drug within 48 hours of fever. IMCI
was in use in this district at the time of the pilot imple-
mentation. The pilot implementation and subsequent
evaluations coincided with the onset of the high transmis-
sion season in this district.
Of a possible 14, a convenience sample of six rural, public
dispensaries were purposively chosen with the help of the
Council Health Management Team (CHMT) based on: a)
geographical range and logistic feasibility in reaching the
areas during rainy season, b) having adequate facility uti-
lization rates in order to achieve the desired sample size
and c) representation of the five "cascade" areas (areas of
CHMT supervision). These facilities represented the low-
est level of peripheral care – none had microscopy services
at the time of the study.
Study Implementation, data collection and analysis
Both quantitative and qualitative methods were used to
evaluate this pilot implementation of RDTs over an eight
week period.
Baseline data collection
Following training, data were collected sequentially on all
patients attending the selected dispensaries, regardless of
diagnosis, as part of a baseline health facility survey
(HFS). The following were excluded: woman known to be
pregnant, trauma patients, those presenting with signs
and symptoms of severe malaria, and those refusing or
unable to provide informed consent or assent. A sampleMalaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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of approximately 100 patients per dispensary (total n =
600) was estimated to be required for evaluation RDT
quality, using an expected sensitivity of 99% and a least
acceptable sensitivity of 95% with 95% confidence and
80% power. This sample size calculation was based upon
an expectation that approximately 34% of patients with a
clinical diagnosis of malaria would be parasitemic and
RDT positive[15]. This sample size was also sufficient to
evaluate other health facility survey variables.
Following the consultation with the provider, a study
team member conducted an exit interview with eligible
patients that collected information on demographics, pre-
senting symptoms, diagnoses and treatments prescribed.
Following this exit interview, a study laboratory techni-
cian collected a finger-prick blood sample, prepared a
thick and thin blood film for malaria microscopy and per-
formed a RDT. Results were recorded on a standardized
case reporting form. The patient register, maintained by
the dispensary staff, was reviewed by study staff to gather
information on the number of patients seen per day, diag-
noses recorded and treatments prescribed.
Microscopy
Microscopy was considered the gold standard. Staining
and microscopy was conducted by a study microscopist
stationed at one of the study sites. Microscopic examina-
tion of the blood was done according to standard tech-
niques. Slides were stained with 10% Giemsa and
leukocytes were counted in the same fields until 200 leu-
kocytes were counted. Parasite densities were calculated
using an assumed leukocyte count of 6,000 leukocytes per
μl of blood.
A second expert microscopist, stationed at the district hos-
pital, reviewed blood films where there were discordant
microscopy and RDT results. If there was further discord-
ance between the two study microscopists, a third study
microscopist stationed at a different district in the same
region, reviewed the film. All microscopists were blinded
to the results of the corresponding RDT and the readings
of the other microscopists.
Malaria RDTs
"Paracheck Pf," manufactured by Orchid Biomedical Sys-
tems (India), was chosen with input from the Tanzanian
NMCP and because it complied with WHO quality con-
trol standards. This test used a histidine-rich protein-2
(HRP-2) detection system for P. falciparum, with reported
sensitivities of 99% and specificities of 100% for Plasmo-
dium falciparum by the manufacturer. The Malaria Labora-
tory Research and Development Unit at the Centers for
Disease Control and Prevention tested sensitivity and spe-
cificity against known samples of varying density and heat
stability (as recommended by WHO), using a selection of
RDTs from the same lot as used in the implementation
and found them to meet the manufacturer's stated sensi-
tivity and specificity. The results of the test are read 15
minutes after the test has been conducted. This RDT was
used during the baseline HFS according to the manufac-
turer's instructions at the selected dispensaries.
RDT training
Following the HFS and prior to RDT implementation at
the selected sites, RDT training was conducted with the
dispensary staff that would be involved with using the
RDTs in this evaluation over a two-day period and
included information about diagnosis and treatment
algorithms, RDT referral criteria, and RDT use (including
general information, limitations of test, how to perform
the test, test result interpretation, troubleshooting, storage
and handling of the test). It also included a session
focused on practice using the RDT on known positive and
negative samples. The level of training provided exceeded
what has generally been provided at other sites of imple-
mentation, which often has been quite minimal or not
described well in implementation studies[2,3,16-18].
Facility staff were responsible for all aspects of the RDT
implementation and each dispensary identified the staff
person that would be conducting and interpreting the
RDT results. The training for the providers was developed
with input from the Mkuranga District Council Manage-
ment Health Team in order to mimic local conditions of
how a new diagnostic technique would be introduced.
Algorithms based on the Tanzanian Malaria Treatment
Guidelines were used as training guides for best practice
but, as in actual practice, during the duration of the study,
the providers made independent decisions about clinical
management of each patient. During training, providers
were instructed that a positive RDT result indicated
malaria and were encouraged to prescribe antimalarials as
per national guidelines. With a negative RDT result, pro-
viders were instructed that this indicated no malaria and
other causes of febrile illnesses should be investigated. In
this case, no antimalarials should be prescribed but other
treatments should be utilized as indicated. Providers were
encouraged to consider RDTs for all eligible patients (at
three dispensaries – all ages, at the other three dispensa-
ries – only those over five years of age) with a suspected
clinical diagnosis of uncomplicated malaria for RDTs dur-
ing the subsequent eight weeks.
RDT implementation
Upon completion of training, sufficient supplies of RDTs
(Paracheck) were distributed to each dispensary. Use of
RDTs was at the discretion of the facility staff. Although
study staff visited each dispensary during implementation
to observe the process, document operational concerns
related to implementation, and during evaluation periodsMalaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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obtain consent and collect daily study recording forms,
there was minimal interactive supervision from the study
staff. So as to approximate normal working conditions,
the study team did not supply watches or clocks to the dis-
pensaries; thus, each person conducting the test devised a
way to monitor or estimate the time required for reading
of the test.
Daily data collection
Throughout the eight weeks of implementation, dispen-
sary staff maintained daily registers recording, by individ-
ual patient, whether a RDT was performed, the RDT
results, diagnosis made, and the treatment prescribed.
Data from these registers were collected and compiled by
study staff and summarized daily onto standardized
forms. Variables, by day, included age category of patient
(≤ or > 5 years of age), number of RDTs performed, RDT
results, and antimalarials prescribed.
Analysis of quantitative data
Data were entered in Tanzania at Ifakara Health Research
and Development Centre using Microsoft Fox Pro soft-
ware for quantitative data and Microsoft Word for quali-
tative data (Microsoft, Seattle, WA, USA). Quantitative
data were analysed using SAS V8 (SAS Institute Inc., Cary,
NC, USA). Frequency distributions were calculated and
differences in proportions were assessed by Chi-square or
Fisher's exact tests. RDT results were characterized by true
positive, true negative, false positive and false negative as
compared to microscopy.
"Correct" prescription of antimalarials is defined as those
with positive RDT who were prescribed antimalarial and
those with negative RDT who were not prescribed antima-
larials. "Overprescription" is defined as those with a clin-
ical diagnosis of malaria and who were RDT negative, but
who were prescribed antimalarials.
Qualitative evaluation periods
There were two qualitative evaluation periods during
implementation. These occurred during weeks four and
eight. During these periods, data were only collected on
the first 80 patients seen.
Qualitative instrument development
All qualitative interview guides were developed with input
from the Tanzanian supervisory staff on the project.
Guides were translated into KiSwahilli and back trans-
lated to English, followed by pilot testing. Modifications
to language and procedures were completed as necessary.
Qualitative interviews
During the two evaluation weeks (four and eight of the
pilot implementation period), 25–30 patients referred for
RDTS per dispensary were recruited to participate in qual-
itative exit interviews. For patients under age five years,
parents or caregivers were interviews. Once consented,
exit interviews were conducted in KiSwahilli (primary lan-
guage for Tanzania) and later transcribed to English. All
providers who used the RDTs were asked to participate in
individual interviews and all facility staff that were
involved in any aspect of using the RDTs were asked to
participate in informal discussions at each dispensary.
Field notes were recorded during these discussions and
later transcribed for analysis. The majority of the provider
interviews and informal discussions were conducted in
KiSwahli. The interviews were transcribed and translated
to English by members of the study team. Using content
analysis techniques, themes were identified from the
interview data. Frequency counts were done on each iden-
tified theme to determine the strength of the theme. Data
were examined across the six sites and the two evaluation
periods by the lead author.
Human subjects' protection
The research protocol was approved by institutional
review boards at CDC and the National Medical Research
Coordinating Committee at the National Institute for
Medical Research in Tanzania. Informed consent for all
procedures and interviews was obtained from all study
participants and there were no refusals.
Results
Sensitivity and specificity
Among the baseline survey of the population (n = 595),
clinical diagnosis, as compared to gold standard micros-
copy, had a sensitivity of 74.5% and specificity of 45%.
RDTs had a sensitivity of 94.4% and specificity of 88.6%
compared to microscopy for infections with parasite den-
sity greater than 100 parasites per uL.
Baseline health facility survey
595 patients attending the selected six dispensaries in
Mkuranga District were surveyed. Selected characteristics
of the surveyed population are presented in Table 1. Of
these, 196 (32.9%) were under five years of age. Overall
clinical malaria (as determined by the provider) was
reported in 365 (61.3%) of the surveyed population. Par-
asite prevalence (as determined by microscopy) was
31.9% (95% confidence interval [CI] 28.2–35.7) with a
geometric mean parasite density of 2076 parasites per uL.
Table 1: Characteristics of survey population (n = 595)
Characteristic n (%) [95% CI]
< 5 years of age 196 (32.9)
Clinical malaria 365 (61.3)
Parasite prevalence 190 (31.9) [28.2–35.7]
Geometric mean parasite density 2076 [1563.5–2757.0]Malaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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Of the 595 patients included in the baseline HFS, 165
(28%) with a clinical diagnosis of malaria had a positive
RDT, 200 (33%) with a clinical diagnosis of malaria had
a negative RDT, 172 (29%) did not have a clinical diagno-
sis of malaria and had a corresponding negative RDT,
while 58 (10%) with no malaria diagnosis had a positive
RDT.
Among those with a clinical diagnosis of malaria (n =
365), 200 (55%) had a negative RDT, representing the
proportion of "overdiagnosis" in this survey population.
Overdiagnosis was observed in 44 (30%) and 156 (72%)
of participants aged < 5 (n = 196) and ≥ 5 (n = 399) years
of age respectively.
Among those prescribed antimalarials (in this survey, all
those with a clinical diagnosis of malaria, n = 356), sul-
phadoxine-pyrimethamine was the most commonly pre-
scribed (70%), followed by amodiaquine (27%), and
quinine (1%). No ACTs or chloroquine were prescribed.
Implementation of RDTs
Each facility determined the staff member who would be
responsible for implementing the RDTs. All six facilities
obtained watches on their own in order to read the test
result at the correct time specified by the manufacturer.
Appropriate use of RDTs by providers
Over the eight week implementation period, 2,519 RDTs
were performed. Among those having an RDT performed,
1,329 (52.8%) had a positive test and were prescribed
antimalarials and 879 (34.9%) had a negative test and no
antimalarials were prescribed; 289 (11.5%) with a nega-
tive test had antimalarials prescribed, while 22 (0.9%)
had a positive test but no antimalarials prescribed.
Figure 1 presents the percent of 'over-prescriptions,'
defined as the proportion of those with a negative RDT
who were prescribed antimalarials among all those pre-
scribed antimalarials, by week of implementation. Prior
to implementation the proportion of "over-prescriptions"
based upon the baseline HFS was 54.8% (n = 198/365).
At week four of implementation, the proportion had
decreased to 16.1% (n = 27/168) and at week eight, it was
16.4% (n = 42/256).
Figure 2 shows the proportion of over-prescriptions by
age at baseline, week four, and week eight of implementa-
tion. Over-prescription was substantially higher among
those equal to and above five years of age; however, the
proportion declined across both age categories over the
eight week period of the study, from 29.5% to 3.9%
among those < five years of age and from 71.9% to 24.7%
among those ≥ five years of age.
Proportion of antimalarial overprescriptions* by RDT implementation week Figure 1
Proportion of antimalarial overprescriptions* by RDT implementation week.
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Perceptions of RDTs by providers
Individual provider interviews
Twenty-one providers were interviewed (ten during week
four, 11 during week eight), most of them clinical officers
with an average of eight years of clinical experience. There
was remarkable similarity in findings across sites and eval-
uation periods.
The majority of the providers (n = 16, 76.2%) had had no
previous experience with any type of rapid diagnostic test.
Virtually all providers agreed that RDTs improved prac-
tice, were feasible for use at dispensary level and enhanced
appropriate treatment. The providers perceived that
patients were happy with the test, as the patients felt that
RDTs improved treatment. The test was seen as being
quick, easy to use and simple. The majority of providers
agreed that the tests made their jobs easier as they were
now more confident with their diagnoses.
There was unanimous agreement from the providers that
they trusted the results, however, this did not mean that
the test results were used in all situations to guide pre-
scribing behaviors. Although agreeing that they trusted
the test results, two clinical officers noted that they relied
on clinical symptoms, rather than test results, to guide
prescribing practices. Their opinions did not change over
the course of the eight week period of implementation.
A key theme from the providers was that diagnosis was
easier as the providers could focus on identifying alternate
reasons why a patient might be febrile if the RDT result
was negative. One provider noted that, by week three, he
focused on other potential diagnoses as he saw how many
patients were returning with negative test results. As one
provider explained:
"A patient describes his problems....and you may have more
than one impression. Malaria and urinary track infections
(UTI) have similar symptoms. If you make a test and find that
the patient does not have malaria, you can then think of UTI
and treat it. This simplifies my treatment decisions."
Informal discussions with facility staff
Results from the informal discussions with the facility
staff echoed the findings from the provider interviews.
The tests were viewed in a positive light as they were per-
Proportion of overprescriptions by age category at RDT implementation weeks 0, 4 and 8 Figure 2
Proportion of overprescriptions by age category at RDT implementation weeks 0, 4 and 8.
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ceived to improve the process of diagnosis and patient sat-
isfaction was high. Staff noted that improved patient
satisfaction resulted in large numbers of patients coming
to the clinic and better utilization of their facility. Staff
also discussed that news about the RDTs had spread rap-
idly throughout neighbouring villages and patients who
were not ill with fever came to the dispensaries asking to
be tested for malaria. However, staff were quick to point
out that, in spite of people wanting the test who were not
febrile, the providers were appropriately using the tests
only for 'eligible' patients (as defined by the study guide-
lines).
In both weeks four and eight, staff noted the continued
fears of some members of the communities that the RDTs
were, in actual practice, tests for HIV/AIDs, although they
clarified that these concerns lessened over time. While
staff indicated that the tests were good in that the provider
could feel confident making a malaria diagnosis, they also
said that use of antimalarials for RDT negative patients
continued to occur.
Operational issues
Data from the interviews, informal discussions and field
notes from the study staff indicated that some operational
issues needed attention during the implementation
period. For example, sometimes watches used to time the
results did not function properly. During one non-evalu-
ation week, one dispensary's watch stopped operating
properly, so staff either asked patients to time the results
or they guessed when to read the test result, which
resulted in reading the test results prematurely (observa-
tions by the field staff at the site).
Staff commented that they felt it took a few weeks of prac-
tice to really 'feel comfortable' with using and interpreting
the RDTs. They repeatedly mentioned the issue of the test
results changing over time, i.e., if they re-examined the
test after the allotted 15 minute interval, they would get a
different result. The issue of changing test results after 15
minutes was discussed at both points of evaluation. One
clinical officer summarized, in his quote below, the feel-
ings of many of the providers regarding the problem of a
change from a 'negative' to a 'positive' test:
"You wait to read the result until it is 15 minutes and you see
nothing [negative] but after sometime when you read it again,
you find it is positive with a very thin bar on the testing window.
You prescribe accordingly, when it is negative you give aspirin
and the patient leaves but then you read it after awhile and you
find it has changed into positive. What are we to do? Maybe
this is for patients with scant malaria."
Some staff mentioned that they had difficulty collecting
the appropriate volume of blood – too much blood
applied to the test cassette subsequently obscured the test
strip, making the test result unreadable. They also felt that
the tests were difficult to read in ambient light, particu-
larly during heavy rains. One recurrent problem that facil-
ity staff encountered while using the RDTs, was reading
the cassette when the result line was faint or 'thin,' partic-
ularly if the person doing the reading had poor eyesight.
Junior staff needed to consult with senior staff, even up to
the eighth week of implementation, on interpreting the
test results that they felt were ambiguous (the results in
question were weak positives). With practice, these con-
cerns lessened.
One village health worker described how he dealt with the
issue of results that were difficult to read (see quote
below). The strategy of adding additional minutes prior to
reading the test was a common strategy used in these dis-
pensaries:
"Some RDTs, when you wait 15 minutes, they don't give you
results until you wait for 20 up to 30 minutes...unless you do
extra work of looking/checking [checking the test thoroughly
and properly]. I learned some things, for instance, instead of
using 15 minutes, I used to add one, two or four minutes until
I get accurate results."
Providers also discussed the problem of RDT-negative
patients going to different facilities that had microscopes,
where they were told that they had malaria. The providers
openly questioned whether they had misdiagnosed a
patient due to a faulty RDT or whether the issue was in
faulty microscopy readings. Compounding this problem
were the patients who insisted on being given antimalar-
ials, even if they had tested negative. As one clinical officer
described:
"I had a patient who had symptoms of malaria and I ordered
him to be checked first. After the test results were negative, I
told him it could be due to tiredness and so he should use para-
cetamol first. He refused and begged me to give him SP [sul-
phadoxine-pyrimethamine]. He said that the test lies...if we
have people that do not understand, then they force us to comply
with their demands...they insist to be given antimalarials."
Most staff perceived that the test put a strain on normal
operations and additional staff were needed. At one dis-
pensary, during one day of the first evaluation period, all
staff members, except the Clinical Officer (CO), were
absent. The CO felt that the shortage of staff made use of
RDTs impossible due to the large patient load. All patients
during this day were treated clinically. As well, a smaller
number of facility staff felt that staff remuneration should
also be increased, as there was a perception that health
facility utilization rates had climbed during the time of
the RDT implementation. Due to the frequent absence ofMalaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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staff for illness or trainings, facility staff learned that,
rather than assigning the responsibility of the test to one
staff person, it was necessary that responsibility for the
RDTs be rotated among staff, including down to the level
of nurse's aides and, in one dispensary, the village health
volunteer.
Perceptions of RDTs by patients/caregivers
As with the providers, there were marked similarities in
the data, during both evaluation periods and across all six
sites. A total of 355 patients/caregivers were interviewed
(175 week four, 180 week eight). Of these, 59.2% (210)
were women. Of those interviewed, 90% (n = 317, 3 miss-
ing data) had received a diagnosis of clinical malaria, with
fifty-three percent (n = 186, 1 missing) confirmed with a
positive RDT result.
When asked what they thought of the RDT, most partici-
pants were quite positive about the test. Patients/caregiv-
ers commented that the test allowed the provider to
identify the disease [literally meaning identifies whether
malaria is present or not]; thus, it allowed the provider to
better match the treatment with the disease, which
decreased the use of unnecessary drugs. The test was also
seen as being 'fast.'
The vast majority of participants (97.2%, n = 345) said
that they trusted the RDT results. The main reasons given
for trust in the results centered on: a) the test was
endorsed by experts (providers, laboratorians, outside
experts and the Ministry of Health) and b) the test results
matched the symptoms experienced by the patients.
However, there was an element of conditional trust in
these results. When asked to explain their response about
trusting the RDTs, it was clear that the RDT result was
trusted if the test results matched signs and symptoms of
illness and, thus, confirmed the patients' own view about
their illnesses. The trust was also predicated on the pre-
scribed treatment resulting in the patients improving or
becoming 'cured.'
Five of the eight who did not trust the results said it was
because their symptoms indicated they had malaria so,
therefore, the test must be incorrect. Three were indeci-
sive, illustrated by this comment from a patient:
"I feel malaria but the result is negative. Really, I do not know
if it is accurate or not. But it seems it is inaccurate. Why should
it be negative when I have all the malaria symptoms?"
Patients/caregivers were asked whether they would be wil-
ing to use or have the test used, as an additional proxy
question reflecting trust. The vast majority (n = 345,
97.2%) of patients/caregivers agreed that they would use
the RDTs again. The major reasons cited were that the test
confirms whether malaria is present or not, thus allowing
for use of the most appropriate drugs. They also noted that
the test should be given before taking any medications. As
one person commented:
"When you get a test, you will be sure with the problem facing
you and which treatment will be appropriate to the illness,
rather than using drugs without any test."
For those who would not take the test (n = 5), the main
reason given was that microscopy was better because you
could actually get a count of the parasites.
Patient/caregiver concerns
Initially, there were marked fears that the test would be
used to identify HIV/AIDS and not malaria. Staff needed
to reassure patients that this was a malaria rapid test prior
to getting patients and caregivers to agree to use the RDT.
Recommendations by providers and patients/caregivers
All participants in the study were asked for their ideas on
improving RDT implementation. Facility staff recom-
mended hiring additional staff and providing more train-
ing and supervision during RDT implementation.
Technical recommendations included improving the test
so that it reflected all species and parasite density, as well
as designing it so that 'weak positive' results were not so
problematic for test result interpretation. Providers
encouraged scaling-up RDT implementation so that all
facilities could have access to this diagnostic tool.
More than a third (n = 132, 37.2%) of the patient/caregiv-
ers commented that RDTs should be implemented pro-
grammatically at all levels of health care facilities. In
addition, patients/caregivers felt that RDTs should be pro-
vided for free. Lastly, they mentioned their hope for devel-
opment of additional rapid tests to help diagnosis other
illnesses.
Discussion
RDTs remain an exciting new intervention for malaria
control. Clinical diagnosis leads to over-diagnosis of
malaria and subsequent over-prescription with antimalar-
ials, particularly among older children and adults as con-
firmed in this study and others[2,3,10,19,20]. This study
also demonstrated that over-diagnosis and -prescription
may be reduced through the use of RDTs among this pop-
ulation at peripheral dispensaries in rural Tanzania.
Though not representative, these results are encouraging
and warrant further RDT implementation, supported by
appropriate monitoring and evaluation of this technol-
ogy.Malaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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Findings from the baseline HFS (prior to RDT implemen-
tation) conducted in the selected dispensaries indicated
that 55% of those with clinical malaria had no evidence of
malaria parasitaemia by RDT. This population also repre-
sented the proportion being "over-treated" and, thus,
were the potential target for reduction through the use of
RDTs. Over-treatment decreased from 55% to 16.1% dur-
ing the first four weeks, with this lower level of overtreat-
ment appearing to be sustained over the following weeks
of implementation. This decrease in "overtreatment" over
time may reflect providers increasing confidence with
RDT use and their results, an explanation supported by
providers' comments during the qualitative assessments
of RDT implementation. A small proportion of patients (n
= 22, 0.9%) who were RDT-positive did not receive an
antimalarial. This occurred in spite of pre-implementa-
tion training, which included a suggested treatment algo-
rithm that was approved by the NMCP. By age group, the
reductions in overtreatment were similarly encouraging.
Patients ≥ five years of age appeared to be the group with
the greatest proportion of overtreatment at baseline
(~72%) compared to those < 5 years of age (~30%). Fol-
lowing eight weeks of implementation, the proportion of
overtreatment for those > five years of age had decreased
to ~25%, and among < 5 years of age to ~4%.
A promising finding was the overall positive appraisal of
the test by the staff involved with the RDTs, in spite of ini-
tial concerns about the ability to correctly read the results.
This enthusiasm for the test echoed other recent findings
in the literature[18].
Ignoring negative RDT results and consequently treating
non-malarial fevers with expensive ACTs is a realistic sce-
nario. In addition to the wasted costs of the RDTs and
ACTs, doing so may jeopardize the well-being of patients
by ignoring other potentially life-threatening diseases that
may be responsible for the febrile episodes. By not provid-
ing appropriate treatment, misdiagnosed illness episodes
may become more costly in terms of repeat visits to the
clinics, use of inappropriate medications by private ven-
dors and loss of time from school or employment[21].
Additional emphasis on non-malaria febrile illness diag-
nosis and management needs to be given in order to help
providers consider alternate reasons for fever so that
appropriate non-malaria case management can occur[3].
As well, systems need to be in place for monitoring how
often patients with negative RDT results go to different
facilities where they are given clinical microscopy results
that are contradictory to the RDT results. If patients are
convinced that they have malaria based on how they feel,
they will, most likely, seek alternative ways to confirm
their own perceptions. Health education messages have
always been that microscopy is the 'gold standard' and,
thus, microscopy is often perceived as a higher level of
care than what is routinely given at the most peripheral
level. However, given the poor overall state of microscopy
in most government facilities in peripheral areas, there is
a strong chance that smear readings may be inaccurate,
resulting in continued unnecessary use of antimalarials.
The problem is that patients, caregivers and even most
peripheral health care workers do not have the technical
skills or expertise to determine the underlying cause of
discrepant test results. There is a potential for increased
mistrust in RDT results, should a lot of patients seek alter-
nate malaria confirmation using unreliable microscopy
results. To prevent or lessen this possibility, Ministries of
Health need to improve facility-based microscopy, in con-
junction with RDT implementation[22]. Expertise in
microscopy is also essential for providing quality control
for the introduction and maintenance of RDTs, providing
parasite counts and diagnosing other diseases[23,24].
Ill patients want to have a diagnosis for their illnesses. The
RDT allowed patients and caregivers to quickly learn
whether malaria was the cause or not, which allowed
them to narrow the possibilities of what might be causing
their symptoms. Satisfaction with having a rapid diagno-
sis was also seen in other RDT implementation stud-
ies[16]. However, community social pressure for
antimalarials is a factor that needs to be considered when
training providers not to prescribe antimalarials with a
negative test result. In time, as RDT-negative individuals
begin to experience clinical improvement without the use
of antimalarials or with treatment for other non-febrile ill-
nesses, this social pressure may wane. Until then, training
should include methods, such as role playing, that might
help providers to better cope with patient expectations.
It is not clear why some providers noted that they used
patients' clinical presentations to guide prescribing prac-
tices, rather than the test results, in spite of saying that
they trusted the results. This may be due to language trans-
lation of the term 'trust' or simply a loss of novelty with a
new intervention and reverting to what had been standard
practice. For years presumptive diagnosis has been the
'rule' in situations where laboratory diagnostics were not
available. Training in the use of RDTs should incorporate
attention to the shift in clinical decision-making that will
be needed when faced with a patient who is RDT negative
but has symptoms compatible with malaria. As well, clini-
cians will need training to assist their patients in under-
standing why different clinical management decisions are
being made when the patient firmly believes that their
symptoms indicate malaria.
The type of training that was provided to the dispensary
level staff was, in all likelihood, more extensive than what
could be provided during a national roll-out of RDTs.Malaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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Although it has been suggested that novice technicians
can competently use RDTs with minimal training[17,25],
it was observed in this study that closer supervision, par-
ticularly during the first week, was needed in order to
assure the health care workers that their techniques were
appropriate. Comments continued up to the eighth week
that more training and supervision was needed. For RDT
implementation to be successful, implementation plan-
ning should include a minimum of two days of training,
followed by regular monthly facility supervision (or bi-
weekly during the first several weeks of implementation).
Routine evaluations should be planned to determine if/
how the test results are affecting prescribing behaviors.
In spite of the more intensive training prior to implemen-
tation and the presence of study staff on-site, the qualita-
tive data indicated that some staff continued to believe
that the 'real' results were seen after the recommendation
time period for reading results. Qualitative findings from
a recent study that examined operational issues related to
use of RDTs in South Africa also confirmed that staff strug-
gled with issues such as not reading the test in a timely
manner or using too much blood. As well, it was noted
that RDTs were in use in spite of insufficient training for
the staff conducting and interpreting the tests[18]. Even
with manufacturing instructions translated to a local lan-
guage and pre-implementation training by a research
team in Myanmar, village health volunteers reported hav-
ing insufficient instructions for test use during a study of
RDT implementation[25]. Given the variability in time in
which test results were read in this study and others, it is
critical that use of the test, as per the manufacturing
instructions, be stressed in trainings for use of RDTs.
Additional data are needed regarding the best length of
training to offer (particularly on-site) and the type and fre-
quency of supervision. Without attention to these issues
pre-implementation, it would be necessary to have fairly
detailed monitoring on-site in order to determine if staff
were using the test and interpreting the results correctly.
Reading the cassette lines was problematic and individu-
als coped with this by simply increasing the length of time
to read the test; thus, potentially increasing the chances
that the test result may not be appropriate. Given the per-
sonnel and financial constraints that most Ministries of
Health operate under, particularly in sub-Saharan Africa,
it may be more feasible to roll-out the intervention slowly
in areas in which supervision will be difficult to provide.
The study findings suggest that a longer period of time
than originally thought may be needed so that staff can
become comfortable in using the tests, before they are
expected to have them as part of their daily service provi-
sion. Offering examples of the types of problems that may
occur (such as problems timing the test) could be
included in the initial training so that the facilities can
begin to think about ways to address common problems.
Prior to national implementation, issues that need atten-
tion include developing: a) effective distribution and
management systems that take into account the need for
temperature-controlled distribution and storage, b)
appropriate instructions for staff with low levels of liter-
acy, assuming that levels of supervision will be minimal,
c) case management strategies for determining RDT eligi-
bility and management of RDT results, and d) quality
assurance and control systems, particularly considering
the likelihood that the RDTs will be stored in less-than-
ideal settings[10,11,26]. As well, given the mistrust of
microscopy results as noted earlier, strengthening micros-
copy diagnostic services should improve clinicians' trust
in microscopy and improve the likelihood that clinicians
accept diagnosis results[3]. Appropriate ways to incorpo-
rate training and supervision for both microscopy and
RDTs should be assessed. Likewise, although data from
modeling suggests that RDTs have the potential to be cost-
effective compared to presumptive treatment[23,27],
additional research is needed to evaluate the cost-effec-
tiveness of these tests when used operationally in various
settings and over extended time periods.
Limitations
There are several limitations that should be mentioned.
This pilot implementation was quite brief and may be an
insufficient period of time to really understand the
dynamics surrounding provider behavior in relationship
to implementing RDTs. The implementation for this eval-
uation focused solely on government health facilities, so
the results cannot be extrapolated to use of RDTs by pri-
vate providers. A study staff member was physically on-
site at all dispensaries during the entire pilot implementa-
tion and all facilities were visited numerous times by the
study supervisory staff, which reflects a "best case sce-
nario" and one that, most likely, will not occur outside of
a research study environment. This level of assistance is
unrealistic when compared to the minimal levels of super-
vision that can be realistically provided by the district
health management teams. The level of training provided
as part of this study may have contributed to the positive
outcomes observed, however, this was not formally
assessed. During the implementation and evaluation peri-
ods, there were no stock outs of tests or drugs as RDTs and
first-line treatment (SP, not the more expensive ACTs)
were always available. Providers were encouraged
throughout implementation to complete a patient regis-
ter, modified from the government issued patient register,
which recorded information about patient demographics
(age and sex), diagnosis, information about why RDTs
were or were not ordered, RDT results and treatment pre-
scribed. The process of completing this log or register mayMalaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
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have positively influenced use of RDTs and their results.
Even so, these interventions may be necessary to guaran-
tee the appropriate use of RDTs and their results. Finally,
this study was conducted at rural dispensaries where
microscopic diagnosis and trained laboratory staff were
unavailable prior to the introduction of RDTs. It is possi-
ble that the culture of doubting frequently inaccurate
blood slide results described elsewhere[1,2] was less
important a factor in this setting.
Conclusions and recommendations
Introduction of RDTs should be considered to improve
rational drug use of newer, more expensive antimalarial
drugs. Prior to full-scale implementation of RDTs, there
are important operational issues that should be consid-
ered. An expanded training of health care workers should
be developed, including the use of clear guidelines to
encourage proper use of RDTs and their results. Identifica-
tion of common potential problems in the field and pos-
sible solutions may be of great value. It is vitally
important that, particularly in resource-poor countries,
the development of training and supervision plans
include not only members of the malaria control pro-
grammes and policy makers but also front-line laboratori-
ans and health staff that will be using and interpreting the
tests. These discussions should realistically examine the
context in which these tests will be implemented[22].
The results of this study suggest that RDTs for malaria can
be implemented effectively and may be highly acceptable
to health care workers, patients and caregivers. The level of
training and supervision provided in this evaluation may
have been greater than other studies, which showed less
promising results[2]. As much as this might limit the gen-
eralizability of the study findings, it also underscores that
many public health officials and malaria policy makers
may have underestimated the intensity of training and
supervision required to ensure adequate deployment of
RDTs for malaria. On-site supervision during the begin-
ning stages of implementation is critical, particularly
focusing on assistance with reinforcing the recommended
timing required for reading of the test results and result
interpretation. Clinical algorithms, with a focus on the
management of other non-malarial febrile illnesses,
should be included in the training and reinforced during
supervisory visits so that providers can appropriately
apply case management. Health utilization rates should
be followed closely over time to determine if additional
staff are needed. Community health education should be
instituted prior to introduction of the RDTs so that
patients/caregivers understand what the test is and how
the results will be used. Lastly, as there remains relatively
little information on the use of RDTs over time, additional
operational research should be conducted to examine if
use or acceptance of the test alters over time and what
measures are necessary to maintain it and assure quality
control in real world delivery systems.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
HAW: co-investigator, conception of study, research pro-
tocol development, over-all project supervision, data
analysis, development and critical review of manuscript.
LC: co-investigator, conception of study, research proto-
col development, over-all project supervision, data analy-
sis, development and critical review of manuscript.
EM: field supervision and data collection, review of man-
uscript.
AM: field supervision and data collection.
TO-R: field supervision and data collection.
SA: conception and design of the study, review of manu-
script.
SPK: conception and design of the study, review of manu-
script.
PBB: conception and design of the study, review of manu-
script.
Acknowledgements
The authors wish to thank the Tanzanian research field and health facility 
staff that participated in the evaluation, as well as Dr. Andrew Kitua of the 
National Institute for Medical Research, Tanzania, for his support of this 
evaluation. We would also like to thank Dr. John Barnwell and his staff at 
the CDC Malaria Reference Laboratory for conducting lot testing of our 
RDTs. Funding was received from United States Aid for International 
Development (USAID) and the CDC.
The findings and conclusions in this report are those of the authors and do 
not necessarily represent the official position of the Centers for Disease 
Control and Prevention.
References
1. Barat L, Chipipa J, Kolczak M, Sukwa T: Does the availability of
blood slide microscopy for malaria at health centers
improve the management of persons with fever in Zambia?
Am J Trop Med Hyg 1999, 60:1024-1030.
2. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley
C, Whitty C: Rapid diagnostic tests compared with malaria
microscopy for guiding outpatient treatment of febrile ill-
ness in Tanzania: randomised trial.  BMJ 2007, 334:403.
3. Hamer D, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda
P, Sipilinyambe N, Simon J, Snow R: Improved diagnostic testing
and malaria treatment practices in Zambia.  JAMA 2007,
297:2227-2231.
4. Zurovac D, Midia B, Ochola SA, English M, Snow RW: Microscopy
and outpatient malaria case management among older chil-
dren and adults in Kenya.  Trop Med Int Health 2006, 11:432-440.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2008, 7:239 http://www.malariajournal.com/content/7/1/239
Page 13 of 13
(page number not for citation purposes)
5. World Health Organization: New perspectives in malaria diag-
nosis. Report of a joint WHO/USAID informal consultation
– 25–27 October, 1999.  Geneva: World Health Organization;
2000:1-57. 
6. Moody A: Rapid diagnostic tests for malaria parasites.  Clin
Microbiol Rev 2002, 15:66-78.
7. Jorgensen P, Chanthap LON, Rebueno A, Tsuyuoka R, Bell D:
Malaria rapid diagnostic tests in tropical climates: the need
for a cool chain.  Am J Trop Med Hyg 2006, 74:750-754.
8. Gilson L, Alilio M, Heggenhougen K: Community satisfaction
with primary health care services: an evaluation undertaken
in the Morogoro region of Tanzania.  Soc Sci Med 1994,
39:767-780.
9. Ofori-Adjei D, Arhinful D: Effect of training on the clinical man-
agement of malaria by medical assistants in Ghana.  Soc Sci
Med 1996, 42:1169-1176.
10. Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK,
Luchavez J, Moody AH, Cenizal A, Bell D: The heat stability of
Plasmodium lactate dehydrogenase-based and histidine-rich
protein 2-based malaria rapid diagnostic tests.  Trans R Soc
Trop Med Hyg 2007, 101:331-337.
11. Chiodini P, Moody A, Hunt-Cooke A: Rapid diagnosis of malaria
by fluorescence microscopy.  Lancet 1991, 337:624-625.
12. Murray CK, Bell D, Gasser RA, Wongsrichanalai C: Rapid diagnos-
tic testing for malaria.  Trop Med Int Health 2003, 8:876-883.
13. McMorrow M, Masanja I, Kachur SP, Abdulla S: Challenges in rou-
tine implementation and quality control of rapid diagnostic
tests for malaria – Rufiji District, Tanzania.  In 56th Annual
Meeting of the American Society of Tropical Medicine and Hygiene Phila-
delphia, PA; 2007. 
14. National Bureau of Statistics, ORC MACRO: Tanzanian Demo-
graphic and Health Survey 2004–5.  Tanzania National Bureau of
Statistics & ORC MACRO; 2005. 
15. Causer L, Abdulla S, Williams H, Shebuge H, Magonyozi D, Msuya H,
Marugo A, Mlila G, Mguilu M, Kachur S, Bloland P: Malaria diagnosis
and the role of diagnostics – Implications for malaria drug
policy.  In American Society of Tropical Medicine and Hygiene Conference
Miami, FL; 2004. 
16. Bell D, Go R, Miguel C, Walker J, Cacal L, Saul A: Diagnosis of
malaria in a remote area of the Philippines: comparison of
techniques and their acceptance by health workers and the
community.  Bull World Health Org 2001, 79:933-941.
17. Causer LM, Bishop HS, Sharp DJ, Flagg EW, Calderon JF, Keane V,
Shah JJ, Macarthur JR, Maloney SA, Cetron MS, Bloland PB: Rapid
malaria screening and targeted treatment of United States-
bound Montagnard refugees from Cambodia in 2002.  Am J
Trop Med Hyg 2005, 72:688-693.
18. Moonasar D, Goga M, Frean J, Kruger P, Chandaramohan D: An
exploratory study of factors that affect the performance and
usage of rapid diagnostic tests for malaria in the Limpopo
Province, South Africa.  Malar J 2007, 6:.
19. Chandramohan D, Jaffar S, Greenwood B: Use of clinical algo-
rithms for diagnosing malaria.  Trop Med Int Health 2002, 7:45-52.
20. Barnish G, Bates I, Iboro J: Newer drug combinations for
malaria.  BMJ 2004, 328:1511-1512.
21. Amexo M, Tolhurst R, Barnish G, Bates I: Malaria misdiagnosis:
effects on the poor and vulnerable.  Lancet 2004, 364:1896-1898.
22. Pang T, Peeling R: Diagnostic tests for infectious diseases in the
developing world: two sides of the coin.  Trans R Soc Trop Med
Hyg 2007, 101:856-857.
23. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills
A: Cost-effectiveness of malaria diagnostic methods in sub-
Saharan Africa in an era of combination therapy.  Bull World
Health Organ 2008, 86(2):101-110.
24. Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Rat-
simbasoa A, Randrianasolo L, Jahevitra M, Andriantsoanirina V,
Menard D: Accuracy and Reliability of Malaria Diagnostic
Techniques for Guiding Febrile Outpatient Treatment in
Malaria-Endemic Countries.  Am J Trop Med Hyg 2008,
78:217-221.
25. Cho Min N, Gatton M: Performance appraisal of rapid on-site
malaria diagnosis (ICT malaria Pf/Pv test) in relation to
human resources at village level in Myanmar.  Acta Trop 2002,
81:13-19.
26. World Health Organization: Malaria rapid diagnosis – making it
work. Meeting report – 20–23 January 2003.  World Health
Organization – Regional Office for the Western Pacific; 2003. 
27. Rolland E, Checchi F, Pinoges L, Balkan S, Guthmann J-P, Guerin PJ:
Operational response to malaria epidemics: are rapid diag-
nostic tests cost-effective?  Trop Med Int Health 2006, 11:398-408.